Vectura Group plc engages in the development of pharmaceutical therapies for the treatment of airways-related diseases. Vectura Group plc was formerly known as Vectura Limited and changed its name to Vectura Group plc in June 2004. The company was incorporated in 1997 and is based in Wiltshire, United Kingdom. As of October 19, 2021, Vectura Group plc operates as a subsidiary of PMI Global Services, Inc.
Research context
Vectura Group plc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Vectura Group plc is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Finally, its free cash flow fell by 67.1% to $3M since the same quarter in the previous year.
Based on the above factors, Vectura Group plc gets an overall score of 2/5.